Sign in

CIK 0001798749

  • Emerging growth company

Jade Biosciences, Inc.

Sign in to watch
Ticker
JBIO
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
831377888
Phone
+1 781-312-3013
Business address
221 CRESCENT ST., BUILDING 23, SUITE 105, WALTHAM, MA, 02453
Former names
Aerovate Therapeutics, Inc.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 84 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2024-04-01 Verwijs Marinus CHIEF TECHNICAL OFFICER Option exercise 10b5-1 +5,300 $14.59 $77K 5,300
2024-04-01 Verwijs Marinus CHIEF TECHNICAL OFFICER Sale 10b5-1 −3,796 $28.87 $110K 1,504
2024-04-01 Verwijs Marinus CHIEF TECHNICAL OFFICER Sale 10b5-1 −1,504 $30.00 $45K 0
2024-04-01 Verwijs Marinus CHIEF TECHNICAL OFFICER Option exercise · Stock Option (Right to Buy) 10b5-1 −5,300 79,400
2024-04-01 NOYES TIMOTHY P CHIEF EXECUTIVE OFFICER Option exercise 10b5-1 +10,000 $2.14 $21K 10,000
2024-04-01 NOYES TIMOTHY P CHIEF EXECUTIVE OFFICER Sale 10b5-1 −4,502 $28.96 $130K 5,498
2024-04-01 NOYES TIMOTHY P CHIEF EXECUTIVE OFFICER Sale 10b5-1 −1,647 $29.90 $49K 3,851
2024-04-01 NOYES TIMOTHY P CHIEF EXECUTIVE OFFICER Sale 10b5-1 −2,851 $31.02 $88K 1,000
2024-04-01 NOYES TIMOTHY P CHIEF EXECUTIVE OFFICER Sale 10b5-1 −1,000 $31.95 $32K 0
2024-04-01 NOYES TIMOTHY P CHIEF EXECUTIVE OFFICER Option exercise · Stock Option (Right to Buy) 10b5-1 −10,000 373,381
2024-04-01 Dake Benjamin T SEE REMARKS Option exercise 10b5-1 +3,325 $10.61 $35K 4,616
2024-04-01 Dake Benjamin T SEE REMARKS Sale 10b5-1 −3,325 $31.97 $106K 1,291
2024-04-01 Dake Benjamin T SEE REMARKS Option exercise · Stock Option (Right to Buy) 10b5-1 −3,325 25,675
2024-04-01 Eldridge George A SEE REMARKS Option exercise 10b5-1 +12,495 $2.14 $27K 14,455
2024-04-01 Eldridge George A SEE REMARKS Sale 10b5-1 −12,495 $31.23 $390K 1,960
2024-04-01 Eldridge George A SEE REMARKS Option exercise · Stock Option (Right to Buy) 10b5-1 −12,495 15,768
2024-03-28 Gillies Hunter CHIEF MEDICAL OFFICER Option exercise 10b5-1 +9,000 $2.14 $19K 12,251
2024-03-28 Gillies Hunter CHIEF MEDICAL OFFICER Sale 10b5-1 −9,000 $29.50 $266K 3,251
2024-03-28 Gillies Hunter CHIEF MEDICAL OFFICER Option exercise · Stock Option (Right to Buy) 10b5-1 −9,000 89,510
2024-03-27 Dake Benjamin T SEE REMARKS Option exercise 10b5-1 +11,068 $10.61 $117K 12,359

Page 5 of 16 · 315 trades